Needle Free Drug Delivery Devices Market Size, Share & Trends Analysis Report By Technology, By Application (Vaccine Delivery, Pain Management, Insulin Delivery, Pediatric Injections), And Segment Forecasts, 2018 - 2024

  • ID: 4582067
  • Report
  • 90 pages
  • Grand View Research
1 of 5

FEATURED COMPANIES

  • 3M
  • Akra Dermojet
  • Antares Pharma, Inc.
  • Injex Pharma AG
  • Penjet Corporation
  • PharmaJet
  • MORE
The global needle free drug delivery devices market size is expected to reach USD 14.6 billion by 2024, progressing at a CAGR of 10.2% during the forecast period. Increasing incidence of chronic diseases such as hepatitis A, hepatitis B, West Nile Virus Fever, and AIDS, which are susceptible to transmission due to use of injections, is one of the key factors driving the needle free drug delivery devices market.

According to AVERT, there were 36.7 million people living with AIDS at the end of 2016 and 34 million have died due to HIV till date. The African continent is the most severely affected region, accounting for 70.0% of the total people infected with HIV worldwide. According to WHO, around 350 million people have been chronically infected with hepatitis B. These key factors fuel clinical urgency for adoption of needle free drug delivery devices.

Continuous use of injections to deliver insulin causes pain and increases the risk of transmittance of infectious diseases. Thus, in order to reduce pain and risk associated with injections, the utilization rate of needle free drug delivery devices has increased significantly over the past few years. The trend is likely to grow in the coming years, providing upthrust to the market.

Further Key Findings From the Study Suggest:
  • Based on technology, jet injectors commanded the leading revenue share of 30.0% in 2015, owing to associated benefits such as improved dosage accuracy, better diffusion into tissues, and reduced pain and sharps
  • The transdermal patch segment is expected to expand at a CAGR of over 10.0% owing to introduction of technologically advanced products with associated benefits such as direct drug delivery, ease of use, and less pain
  • The insulin delivery segment held over 33.0% of the market in 2015, which can be attributed to advantages such as self-administration and availability of wide range of devices such as transdermal patches, jet injectors, and inhalers
  • North America dominated the global market with 41.0% share in 2015 owing to increasing number of R&D investments by prominent industry players and high awareness among the patient base regarding novel products
  • The Asia Pacific region is expected to witness a CAGR of over 12.0% during the forecast period owing to presence of huge target population
  • Market players are resorting to sustainability strategies such as product launches, strategic collaborations, mergers & acquisitions, and technological innovations
  • The industry rivalry is high and threat of new entrants is moderate owing to high capital requirement for procuring technology and other intellectual properties from existing companies
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • 3M
  • Akra Dermojet
  • Antares Pharma, Inc.
  • Injex Pharma AG
  • Penjet Corporation
  • PharmaJet
  • MORE
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
1.3. List of Data Sources

Chapter 2. Executive Summary
2.1. Needle Free drug delivery devices market- Industry Snapshot and Key Buying Criteria, 2015

Chapter 3. Needle Free Drug Delivery Devices Industry Outlook
3.1. Needle Free drug delivery devices market Segmentation
3.2. Needle Free drug delivery devices market Size and Growth Prospects
3.3. Needle Free drug delivery devices market Dynamics
3.3.1. Market Driver Analysis
3.3.1.1. Rising incidences of respiratory diseases
3.3.1.2. Technological advancements
3.3.2. Market Restraint Analysis
3.3.2.1. Complex regulatory framework
3.4. Key Opportunities Prioritized
3.5. Needle Free drug delivery devices Competitive Landscape, 2015
3.5.1. Company Market Share Analysis, 2015
3.5.2. Competitive Landscape: Market Position Analysis (based on products, regional presence, and strategic initiatives)
3.6. Industry Analysis - Porter's
3.7. Needle Free drug delivery devices market PESTEL Analysis, 2015

Chapter 4. Needle Free Drug Delivery Devices Technology Outlook
4.1. Needle Free drug delivery devices market Share By technology, 2015 & 2024
4.2. Needle Free drug delivery devices
4.2.1. Needle Free drug delivery devices Market Estimates and Forecasts, 2014 - 2024
4.2.2. Jet Injectors
4.2.2.1. Jet Injectors Market Estimates and Forecasts, 2014 - 2024
4.2.3. Inhaler Technology
4.2.3.1. Inhaler Technologies Market Estimates and Forecasts, 2014 - 2024
4.2.4. Transdermal Patch Technology
4.2.4.1. Transdermal Patch Technology Market Estimates and Forecasts, 2014 - 2024
4.2.5. Novel Needle Free Technologies
4.2.5.1. Novel Needle Free Technologies Market Estimates and Forecasts, 2014 - 2024

Chapter 5. Needle Free Drug Delivery Devices Application Outlook
5.1. Needle Free drug delivery devices market Share By Application, 2015 & 2024
5.2. Vaccine Delivery
5.2.1. Vaccine Delivery Market Estimates and Forecasts, 2014 - 2024
5.3. Pain Management
5.3.1. pain Management Market Estimates and Forecasts, 2014 - 2024
5.4. Obstructive Sleep Apnea
5.4.1. Obstructive Sleep Apnea Market Estimates and Forecasts, 2014 - 2024
5.5. Insulin Delivery for Diabetes
5.5.1. Insulin Delivery for Diabetes Market Estimates and Forecasts, 2014 - 2024
5.6. Pediatric Injections
5.6.1. Pediatric Injections Market Estimates and Forecasts, 2014 - 2024
5.7. Others
5.7.1. Others Market Estimates and Forecasts, 2014 - 2024

Chapter 6. Needle Free Drug Delivery Devices Regional Outlook
6.1. Needle Free drug delivery devices market Share By Region, 2015 & 2024
6.2. North America
6.2.1. North America Market Estimates and Forecasts, By technology, 2014 - 2024 (USD Million)
6.2.1.1. U.S. Market Estimates and Forecasts
6.2.1.2. Canada Market Estimates and Forecasts
6.2.2. North America Market Estimates and Forecasts, By Application, 2014 - 2024 (USD Million)
6.2.2.1. U.S. Market Estimates and Forecasts
6.2.2.2. Canada Market Estimates and Forecasts
6.3. Europe
6.3.1. Europe Market Estimates and Forecasts, By technology, 2014 - 2024 (USD Million)
6.3.1.1. UK Market Estimates and Forecasts
6.3.1.2. Germany Market Estimates and Forecasts
6.3.2. Europe Market Estimates and Forecasts, By Application, 2014 - 2024 (USD Million)
6.3.2.1. UK Market Estimates and Forecasts
6.3.2.2. Germany Market Estimates and Forecasts
6.4. Asia Pacific
6.4.1. Asia Pacific Market Estimates and Forecasts, By technology, 2014 - 2024 (USD Million)
6.4.1.1. Japan Market Estimates and Forecasts
6.4.1.2. China Market Estimates and Forecasts
6.4.1.3. India Market Estimates and Forecasts
6.4.2. Asia Pacific Market Estimates and Forecasts, By Application, 2014 - 2024 (USD Million)
6.4.2.1. Japan Market Estimates and Forecasts
6.4.2.2. China Market Estimates and Forecasts
6.4.2.3. India Market Estimates and Forecasts
6.5. Latin America
6.5.1. Latin America Market Estimates and Forecasts, By technology, 2014 - 2024 (USD Million)
6.5.1.1. Brazil Market Estimates and Forecasts
6.5.1.2. Mexico Market Estimates and Forecasts
6.5.2. Latin America Market Estimates and Forecasts, By Application, 2014 - 2024 (USD Million)
6.5.2.1. Brazil Market Estimates and Forecasts
6.5.2.2. Mexico Market Estimates and Forecasts
6.6. MEA
6.6.1. MEA Market Estimates and Forecasts, By technology, 2014 - 2024 (USD Million)
6.6.1.1. South Africa Market Estimates and Forecasts
6.6.2. MEA Market Estimates and Forecasts, By Application, 2014 - 2024 (USD Million)
6.6.2.1. South Africa Market Estimates and Forecasts

Chapter 7. Competitive Landscape
7.1. Antares Pharma, Inc.
7.1.1. Company Overview
7.1.2. Financial Performance
7.1.3. Product Benchmarking
7.1.4. Strategic Initiatives
7.2. Glide Pharmaceutical Technologies Ltd
7.2.1. Company Overview
7.2.2. Financial Performance
7.2.3. Product Benchmarking
7.2.4. Strategic Initiatives
7.3. Injex Pharma AG
7.3.1. Company Overview
7.3.2. Financial Performance
7.3.3. Product Benchmarking
7.3.4. Strategic Initiatives
7.4. 3M
7.4.1. Company Overview
7.4.2. Financial Performance
7.4.3. Product Benchmarking
7.4.4. Strategic Initiatives
7.5. PharmaJet
7.5.1. Company Overview
7.5.2. Financial Performance
7.5.3. Product Benchmarking
7.5.4. Strategic Initiatives
7.6. Zogenix, Inc.
7.6.1. Company Overview
7.6.2. Financial Performance
7.6.3. Product Benchmarking
7.6.4. Strategic Initiatives’
7.7. BioJect Medical Technologies, Inc.
7.7.1. Company Overview
7.7.2. Financial Performance
7.7.3. Product Benchmarking
7.7.4. Strategic Initiatives
7.8. Penjet Corporation
7.8.1. Company Overview
7.8.2. Financial Performance
7.8.3. Product Benchmarking
7.8.4. Strategic Initiatives
7.9. Valeritas
7.9.1. Company Overview
7.9.2. Financial Performance
7.9.3. Product Benchmarking
7.9.4. Strategic Initiatives
7.10. D'Antonio Consultants International, Inc.
7.10.1. Company Overview
7.10.2. Financial Performance
7.10.3. Product Benchmarking
7.10.4. Strategic Initiatives
7.11. Akra Dermojet
7.11.1. Company Overview
7.11.2. Financial Performance
7.11.3. Product Benchmarking
7.11.4. Strategic Initiatives

List of Tables
Table 1 Needle Free drug delivery devices- Industry Snapshot & Key Buying Criteria, 2014 - 2024
Table 2 Global Needle Free drug delivery devices market, by technology, 2014 - 2024 (USD Million)
Table 3 Global Needle Free drug delivery devices market, by application, 2014 - 2024 (USD Million)
Table 4 Global Needle Free drug delivery devices market, by region, 2014 - 2024 (USD Million)
Table 5 Needle Free drug delivery devices - Key market driver analysis
Table 6 Needle Free drug delivery devices - Key market restraint analysis
Table 7 North America Needle Free drug delivery devices market, by technology, 2014 - 2024 (USD Million)
Table 8 North America Needle Free drug delivery devices market, by application, 2014 - 2024 (USD Million)
Table 9 U.S. Needle Free drug delivery devices market, by technology, 2014 - 2024 (USD Million)
Table 10 U.S. Needle Free drug delivery devices market, by application, 2014 - 2024 (USD Million)
Table 11 Canada Needle Free drug delivery devices market, by technology, 2014 - 2024 (USD Million)
Table 12 Canada Needle Free drug delivery devices market, by application, 2014 - 2024 (USD Million)
Table 13 Europe Needle Free drug delivery devices market, by technology, 2014 - 2024 (USD Million)
Table 14 Europe Needle Free drug delivery devices market, by application, 2014 - 2024 (USD Million)
Table 15 UK Needle Free drug delivery devices market, by technology, 2014 - 2024 (USD Million)
Table 16 UK Needle Free drug delivery devices market, by application, 2014 - 2024 (USD Million)
Table 17 Germany Needle Free drug delivery devices market, by technology, 2014 - 2024 (USD Million)
Table 18 Germany Needle Free drug delivery devices market, by application, 2014 - 2024 (USD Million)
Table 19 Asia Pacific Needle Free drug delivery devices market, by technology, 2014 - 2024 (USD Million)
Table 20 Asia Pacific Needle Free drug delivery devices market, by application, 2014 - 2024 (USD Million)
Table 21 Japan Needle Free drug delivery devices market, by technology, 2014 - 2024 (USD Million)
Table 22 Japan Needle Free drug delivery devices market, by application, 2014 - 2024 (USD Million)
Table 23 China Needle Free drug delivery devices market, by technology, 2014 - 2024 (USD Million)
Table 24 China Needle Free drug delivery devices market, by application, 2014 - 2024 (USD Million)
Table 25 India Needle Free drug delivery devices market, by technology, 2014 - 2024 (USD Million)
Table 26 India Needle Free drug delivery devices market, by application, 2014 - 2024 (USD Million)
Table 27 Latin America Needle Free drug delivery devices market, by technology, 2014 - 2024 (USD Million)
Table 28 Latin America Needle Free drug delivery devices market, by application, 2014 - 2024 (USD Million)
Table 29 Brazil Needle Free drug delivery devices market, by technology, 2014 - 2024 (USD Million)
Table 30 Brazil Needle Free drug delivery devices market, by application, 2014 - 2024 (USD Million)
Table 31 Mexico Needle Free drug delivery devices market, by technology, 2014 - 2024 (USD Million)
Table 32 Mexico Needle Free drug delivery devices market, by application, 2014 - 2024 (USD Million)
Table 33 MEA Needle Free drug delivery devices market, by technology, 2014 - 2024 (USD Million)
Table 34 MEA Needle Free drug delivery devices market, by application, 2014 - 2024 (USD Million)
Table 35 South Africa Needle Free drug delivery devices market, by technology, 2014 - 2024 (USD Million)
Table 36 South Africa Needle Free drug delivery devices market, by application, 2014 - 2024 (USD Million)

List of Figures
FIG. 1 Needle Free drug delivery devices : Market segmentation
FIG. 2 Global Needle Free drug delivery devices market, 2012 - 2022 (USD Million)
FIG. 3 Needle Free drug delivery devices : Market dynamics
FIG. 4 Key opportunities prioritized, 2014
FIG. 5 Needle Free drug delivery devices company market share, 2014
FIG. 6 Competitive Landscape Analysis, 2014
FIG. 7 Needle Free drug delivery devices market - Porter’s analysis
FIG. 8 Needle Free drug delivery devices market - PESTEL analysis
FIG. 9 Needle Free drug delivery devices revenue share, by technology, 2015 & 2024
FIG. 10 Needle Free drug delivery devices market, 2014 - 2024 (USD Million)
FIG. 11 Jet injectors market, 2014 - 2024 (USD Million)
FIG. 12 Inhaler technology market, 2014 - 2024 (USD Million)
FIG. 13 Transdermal patch technology market, 2014 - 2024 (USD Million)
FIG. 14 Novel Needle Free technologies market, 2014 - 2024 (USD Million)
FIG. 15 Needle Free drug delivery devices market, 2014 - 2024 (USD Million)
FIG. 16 Needle Free drug delivery devices revenue share, application, 2015 & 2024
FIG. 17 Vaccine delivery market, 2014 - 2024 (USD Million)
FIG. 18 Pain management market, 2014 - 2024 (USD Million)
FIG. 19 Insulin delivery for diabetes market, 2014 - 2024 (USD Million)
FIG. 20 Pediatric injections market, 2014 - 2024 (USD Million)
FIG. 21 Others market, 2014 - 2024 (USD Million)
FIG. 22 Needle Free drug delivery devices market share, by region, 2015 & 2024
FIG. 23 North America Needle Free drug delivery devices market, 2014 - 2024 (USD Million)
FIG. 24 U.S. Needle Free drug delivery devices market, 2014 - 2024 (USD Million)
FIG. 25 Canada Needle Free drug delivery devices market, 2014 - 2024 (USD Million)
FIG. 26 Europe Needle Free drug delivery devices market, 2014 - 2024 (USD Million)
FIG. 27 UK Needle Free drug delivery devices market, 2014 - 2024 (USD Million)
FIG. 28 Germany Needle Free drug delivery devices market, 2014 - 2024 (USD Million)
FIG. 29 Asia Pacific Needle Free drug delivery devices market, 2014 - 2024 (USD Million)
FIG. 30 Japan Needle Free drug delivery devices market, 2014 - 2024 (USD Million)
FIG. 31 China Needle Free drug delivery devices market, 2014 - 2024 (USD Million)
FIG. 32 India Needle Free drug delivery devices market, 2014 - 2024 (USD Million)
FIG. 33 Latin America Needle Free drug delivery devices market, 2014 - 2024 (USD Million)
FIG. 34 Brazil Needle Free drug delivery devices market, 2014 - 2024 (USD Million)
FIG. 35 Mexico Needle Free drug delivery devices market, 2014 - 2024 (USD Million)
FIG. 36 MEA Needle Free drug delivery devices market, 2014 - 2024 (USD Million)
FIG. 37 South Africa Needle Free drug delivery devices market, 2014 - 2024 (USD Million)
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
  • Antares Pharma, Inc.
  • Glide Pharmaceutical Technologies Ltd
  • Injex Pharma AG
  • 3M
  • PharmaJet
  • Zogenix, Inc.
  • BioJect Medical Technologies, Inc.
  • Penjet Corporation
  • Valeritas
  • D'Antonio Consultants International, Inc.
  • Akra Dermojet
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown
Adroll
adroll